X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AJANTA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
TEVA PHARMA
Dec-13
AJANTA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7202,683-   
Low Rs1,1032,331-   
Sales per share (Unadj.) Rs194.61,539.8-  
Earnings per share (Unadj.) Rs45.296.2-  
Cash flow per share (Unadj.) Rs50.3220.7-  
Dividends per share (Unadj.) Rs8.0084.21-  
Dividend yield (eoy) %0.63.4 16.9%  
Book value per share (Unadj.) Rs132.01,710.5-  
Shares outstanding (eoy) m88.77848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.31.6 445.5%   
Avg P/E ratio x31.226.1 119.8%  
P/CF ratio (eoy) x28.111.4 247.0%  
Price / Book Value ratio x10.71.5 729.4%  
Dividend payout %17.787.5 20.2%   
Avg Mkt Cap Rs m125,2992,125,868 5.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,5700-   
Avg. sales/employee Rs ThNM29,052.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,814.9-  
INCOME DATA
Net Sales Rs m17,2751,305,784 1.3%  
Other income Rs m1660-   
Total revenues Rs m17,4421,305,784 1.3%   
Gross profit Rs m5,807357,590 1.6%  
Depreciation Rs m451105,548 0.4%   
Interest Rs m4925,648 0.2%   
Profit before tax Rs m5,474226,394 2.4%   
Minority Interest Rs m01,028 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-148,615 0.0%   
Tax Rs m1,460-2,764 -52.8%   
Profit after tax Rs m4,01481,571 4.9%  
Gross profit margin %33.627.4 122.8%  
Effective tax rate %26.7-1.2 -2,184.4%   
Net profit margin %23.26.2 372.0%  
BALANCE SHEET DATA
Current assets Rs m7,639881,922 0.9%   
Current liabilities Rs m2,715769,110 0.4%   
Net working cap to sales %28.58.6 329.9%  
Current ratio x2.81.1 245.4%  
Inventory Days Days4391 47.6%  
Debtors Days Days7996 82.0%  
Net fixed assets Rs m6,914426,498 1.6%   
Share capital Rs m1773,214 5.5%   
"Free" reserves Rs m11,4420-   
Net worth Rs m11,7211,450,478 0.8%   
Long term debt Rs m149667,676 0.0%   
Total assets Rs m14,8142,984,135 0.5%  
Interest coverage x112.99.8 1,149.3%   
Debt to equity ratio x00.5 2.8%  
Sales to assets ratio x1.20.4 266.5%   
Return on assets %27.43.6 763.3%  
Return on equity %34.25.6 609.0%  
Return on capital %46.54.9 943.6%  
Exports to sales %55.10-   
Imports to sales %6.00-   
Net fx Rs m8,7440-   
CASH FLOW
From Operations Rs m3,264208,074 1.6%  
From Investments Rs m-2,093-73,729 2.8%  
From Financial Activity Rs m-1,186-249,599 0.5%  
Net Cashflow Rs m-15-115,254 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.28 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare AJANTA PHARMA With: PLETHICO PHARMA  LUPIN LTD  FULFORD INDIA  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 16, 2017 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS